Dong-A ST Competitors and Similar CompaniesClear all

Dong-A ST's competitors and similar companies include Phapros, Cosmo Pharmaceuticals, TRB Chemedica and Nobelpharma.

	Dong-A ST Dong-A ST is a healthcare company that specializes in the development of ethical drugs and medical devices.	Phapros PT Phapros Tbk is engaged in pharmaceutical manufacturing.	Cosmo Pharmaceuticals Cosmo Pharmaceuticals is a company that focuses on solutions in the areas of astroenterology and endoscopy.	TRB Chemedica TRB Chemedica is a company specializing in the production of active pharmaceutical ingredients (APIs), pharmaceutical products, and medical devices.	Nobelpharma Nobelpharma (ノーベルファーマ) is a pharmaceutical company that is engaged in the research and development of medicines and medical devices.
Founding Date	Founding Date 1932	Founding Date 1954	Founding Date 1997	Founding Date 1980	Founding Date 2003
Type	Type Public	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech drug development medical devices medtech pharma	Tags Healthcare drug development medical devices medtech pharma	Tags Healthcare biotech drug development medical devices pharma	Tags Healthcare biotech drug development medical devices pharma	Tags Healthcare biotech drug development medical devices pharma
Locations	Locations HQ	Locations HQ	Locations Dublin, IE HQ	Locations Genève, CH HQ Buenos Aires, AR Biedermannsdorf, AT Campinas, BR Archamps, FR Feldkirchen, DE Sai Ying Pun, HK see more	Locations Chuo City, JP HQ
Employees	Employees 1,533	Employees N/A	Employees 339	Employees 900	Employees 269
Financial
Revenue (est.)	Revenue (est.) ₩664b (FY, 2023)	Revenue (est.) N/A	Revenue (est.) €92.8m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods ₩315.4b (FY, 2023)	Cost of goods N/A	Cost of goods €21.8m (FY, 2023)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit ₩357b (FY, 2023)	Gross profit N/A	Gross profit €72.5m (FY, 2023)	Gross profit N/A	Gross profit N/A
Net income	Net income ₩2b (FY, 2023)	Net income N/A	Net income (€4.7m) (FY, 2023)	Net income N/A	Net income N/A